Security key
501147102
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 20,879,536
- Total 13F value
- $1,455,390,527
- Share change
- +32,110
- Put/Call ratio
- 348%
- SEC-reported price per share
- $69.70
- Number of holders
- 141
- Value change
- +$2,509,281
- Number of buys
- 77
- Number of sells
- 46
- Shares outstanding
- 29,625,982
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2022
Institutions
141
Top holders
10
KRYS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
Krystal Biotech, Inc. SEC filings
Krystal Biotech, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 501147102
Recent filing periods:
Ownership snapshot
Top reported holders of KRYS - Krystal Biotech, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
0/15
Latest evidence
30 Jun 2022
13F
Highest disclosed value: $138,296,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC has the largest disclosed position value at $138.3M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Disclosed position value
Top 5
FMR LLC
$138.3M
Redmile Group, LLC
$124.66M
BlackRock Finance, Inc.
$111.71M
Point72 Asset Management, L.P.
$103.37M
LORD, ABBETT & CO. LLC
$73.38M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
—
denominator unverified
|
$138,296,000
2,106,249 shares
|
— | 30 Jun 2022 |
| Redmile Group, LLC |
13F
Company
|
—
denominator unverified
|
$124,658,000
1,898,545 shares
|
— | 30 Jun 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$111,709,000
1,701,322 shares
|
— | 30 Jun 2022 |
| Point72 Asset Management, L.P. |
13F
Company
|
—
denominator unverified
|
$103,367,000
1,574,275 shares
|
— | 30 Jun 2022 |
| LORD, ABBETT & CO. LLC |
13F
Company
|
—
denominator unverified
|
$73,379,000
1,117,566 shares
|
— | 30 Jun 2022 |
| Frazier Life Sciences Management, L.P. |
13F
Company
|
—
denominator unverified
|
$71,924,000
1,095,407 shares
|
— | 30 Jun 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
141
Shares
20,879,536
Rows available
141
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
129
Q3 2022 holders
141
Holder diff
12
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 value | Q3 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend